Factors associated with offer and uptake of provider-initiated HIV testing and counselling among men attending healthcare facilities in Moshi Municipality, Northern Tanzania
PLOS ONE · 20.09.2023 · 18 (9) · e0291792
DOI: 10.1371/journal.pone.0291792 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS ONE, online erschienen am 20.09.2023. Verfasst von Hellen Kyilyosudu und 3 weiteren Autor:innen. Beteiligte Einrichtung: Institute of Public Health, Department of Community Health, Kilimanjaro Christian Medical University College (KCMUCo), Moshi, Tanzania. Hauptthemen laut MEDLINE: HIV Seropositivity, HIV-1. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 28 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
HIV Testing and Counseling is a critical entry-point for HIV care, treatment and prevention. Tanzania adopted the WHO recommendations of Provider-Initiated HIV Testing and Counseling (PITC) in 2007 with the aim of increasing early HIV diagnosis and timely access to treatment and support services. However, approximately 55% of men are still unaware of their HIV status. This study aimed to determine the level of PITC uptake and factors associated with PITC availability and uptake among men attending healthcare facilities in Moshi Municipality, Northern Tanzania.
Method
A facility-based cross-sectional study was conducted in July 2019 in five selected healthcare facilities in Moshi Municipal, Kilimanjaro region. Exit interviews were conducted with men aged 18 years and above who attended for care in the selected facilities. Modified Poisson regression modelling with robust standard errors were used to determine factors independently associated with being offered and accepting the PITC offer.
Results
A total of 562 men participated in this study. The median age of participants at enrollment was 37 (IQR: 26–59) years. Only 58% of participants reported to have been offered provider-initiated HIV counseling. Of these, 83% accepted the offer of HIV testing. Age between 35–59 years (aPR = 1.2; 95% Confidence Interval (CI): 1.0, 1.4; p = 0.033) and having primary education (aPR = 0.7; 95% CI: 0.6, 0.9; p = 0.010) were factors independently associated with being offered PITC. Age between 35–59 years (aPR = 0.8; 95% CI: 0.7, 0.9; p = 0.002); having been previously tested for HIV (aPR = 1.3; 95% CI: 1.1, 1.5; p = 0.011) and visiting a health facility twice or more in previous year (aPR = 1.3; 95% CI: 1.2, 1.5; p
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Institute of Public Health, Department of Community Health, Kilimanjaro Christian Medical University College (KCMUCo), Moshi, Tanzania.
- St. Joseph Council Designated Hospital, Moshi, Tanzania.
- Institute of Public Health, Department of Epidemiology & Biostatistics, Kilimanjaro Christian Medical University College (KCMUCo), Moshi, Tanzania.
- Department of Community Medicine, Kilimanjaro Christian Medical Centre (KCMC), Moshi, Tanzania.
ORCID-Profile: Damian J Damian
Zitieren
APA
Kyilyosudu, H., Msuya, S. E., Ngocho, J. S., & Damian, D. J. (2023). Factors associated with offer and uptake of provider-initiated HIV testing and counselling among men attending healthcare facilities in Moshi Municipality, Northern Tanzania. PLOS ONE, 18(9), e0291792. https://doi.org/10.1371/journal.pone.0291792
Vancouver
Kyilyosudu H, Msuya SE, Ngocho JS, Damian DJ. Factors associated with offer and uptake of provider-initiated HIV testing and counselling among men attending healthcare facilities in Moshi Municipality, Northern Tanzania. PLOS ONE. 2023;18(9):e0291792. doi:10.1371/journal.pone.0291792
BibTeX
@article{Kyilyosudu2023,
author = {Kyilyosudu, Hellen and Msuya, Sia E and Ngocho, James S and Damian, Damian J},
title = {Factors associated with offer and uptake of provider-initiated HIV testing and counselling among men attending healthcare facilities in Moshi Municipality, Northern Tanzania},
journal = {PLOS ONE},
year = {2023},
volume = {18},
number = {9},
pages = {e0291792},
doi = {10.1371/journal.pone.0291792}
}
EUVIMED